ロード中...
Bordetella pertussis Isolates with a Heterogeneous Phenotype for Erythromycin Resistance
Erythromycin is currently being used for both prophylaxis and treatment of pertussis infections. Erythromycin resistance was first recognized in Bordetella pertussis in Arizona in 1994, and since then, three additional resistant isolates have been identified in the United States. To better assess th...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2002
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC120648/ https://ncbi.nlm.nih.gov/pubmed/12149356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.40.8.2942-2944.2002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|